CN102786586A - Discovery of peptide toxins in Amanita pallidorosea fermentation mycelium - Google Patents

Discovery of peptide toxins in Amanita pallidorosea fermentation mycelium Download PDF

Info

Publication number
CN102786586A
CN102786586A CN2012102517812A CN201210251781A CN102786586A CN 102786586 A CN102786586 A CN 102786586A CN 2012102517812 A CN2012102517812 A CN 2012102517812A CN 201210251781 A CN201210251781 A CN 201210251781A CN 102786586 A CN102786586 A CN 102786586A
Authority
CN
China
Prior art keywords
amanita
pallidorosea
fermentation
fermentation mycelium
discovery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012102517812A
Other languages
Chinese (zh)
Inventor
包海鹰
张楠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012102517812A priority Critical patent/CN102786586A/en
Publication of CN102786586A publication Critical patent/CN102786586A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention relates to peptide toxins in an Amanita pallidorosea fermentation mycelium, and provides a fermentation preparation method and a fermentation preparation condition. Research results show that the Amanita pallidorosea fermentation mycelium contains alpha-amatoxin and beta-amatoxin. The researches provide a new resource for the obtaining of the toxins.

Description

The anatoxic discovery of peptide in the rose-red goose cream fermentation mycelium
Technical field:
The present invention has studied the peptide toxoid in the rose-red goose cream fermentation mycelium, and fermentation preparation and condition are provided, and research shows that rose-red Amanita fuliginea filament contains α-amanita hemolysin and β-amanita hemolysin.This research obtains to provide new resource for toxin.
Background technology:
Amanita fuliginea is a universal big genus, and in the poisonous mushroom most important one type, that has named at present has kind more than 500 approximately.This genus belongs to Basidiomycotina (Basidiomycotina), Hymenomycetes (Hymenomycetes), Agaricales (Agaricales), amanitaceae (Amanitaceae), Amanita (Amanita Pers.:Gray).Toxin main in the Amanita fuliginea is the peptide toxoid, has 3 big types 22 kinds, is respectively 6 kinds of 9 kinds of amanita hemolysins (amatoxins), 7 kinds of Phallus phallotoxins (phallotoxins) and phalloidins (virotoxins).The peptide toxoid is because the unique biological characteristic; Be widely used in biology, medical science, genetics, biological chemistry, genetically engineered at present; Research fields such as virus; People hope and can make it become the good medicine of curing the disease through its toxic component and pharmaceutical research are found a kind of ideal medicine that this also is when the important research project of forward swing in face of pharmacology and bacteriology worker.Aspect biology, amatoxin is as the molecular biological a kind of instrument of research.
Because most kind of Amanita is the ectomycorrhiza fungi, is difficult to artificial culture, the toxin basic source is in the sporophore of field acquisition.Every milligram of price of toxin source U.S. Sigma company is at 12~140,000 dollars.Because key status and the singularity of its toxin of Amanita in fungi, so the effort of artificial culture Amanita fuliginea never stopped.
Summary of the invention:
The present invention has adopted conventional known method to prepare rose-red goose cream fermentation mycelium, and is specific as follows:
(1) optimum medium (improvement PDM): yam 200g/L, glucose 20g/L, potassium primary phosphate 3g/L; Sal epsom 0.5g/L, phosphoric acid hydrogen ammonia 0.5g/L, calcium chloride 0.05g/L; Saltpetre 0.1g/L, wort (12 degree Beaume) 120ml, vitaminB10 .01g/L.
(2) spawn culture: slant strains inserts an amount of mycelia in the optimum medium after 26 ℃ of constant incubators are cultivated 10d, places on the constant temperature oscillator 150r/min shaking culture 10d then.
Shake flask fermentation: the bottled 100mL nutrient solution of 250mL triangle, inoculum size 5% (v/v) places on 26 ℃ of constant temperature oscillators 150r/min shaking culture 25d.
The present invention has adopted conventional known method to detect the peptide toxoid in the rose-red goose cream fermentation mycelium, and method and result are following:
1. experimental technique
(1) preparation of crude venom: after spawn culture is accomplished,, collect filter residue and filtrating, grind mycelium after the oven dry down at 60 ℃ with filtering fermentation liquor.Get the mycelium powder after 1g grinds, be dissolved in 10ml 50% methyl alcohol, vibration extracting 24h under the room temperature, the centrifugal collection supernatant of 8000r/min.Deposition is with the vibration extracting centrifugal collection of 24h 8000r/min under the 10ml 50% methyl alcohol room temperature and merge supernatant.With sherwood oil degrease twice, lyophilize then, freeze dried sample dissolves with ultrapure water, uses the filtering with microporous membrane of 0.22um again, obtains goose cream crude venom.
(2) separation and purification of toxin: the HPLC location parameter uses Agilent 1100 high performance liquid chromatographs separation gradient mode to be: 0 → 15min, and B 0 → 5%, and A 100% → 95%; 15 → 35min, B 5 → 80%, and A 95% → 20%; 35 → 40min, B 80%, and A 20%; 40-45min, B 80 → 100%, and A 20 → 0%; 45-50min, B 100%; 50 → 55min, B 100 → 0%, and A 0 → 100% also keeps 10min; Purifying gradient mode: with to separate gradient mode identical.Detect wavelength: 295nm; Column temperature: 40 ℃; Flow velocity: analytical column: lmL/min; Semipreparative column: 2mL/min.Sample size: analytical column: 10 μ L, semipreparative column: lmL.
HPLC analyzes separation and the purifying that on semipreparative column, carries out earlier toxin, obtains 5 kinds of compounds, after the lyophilize, identifies with the liquid chromatography mass combined instrument with the HPLC separation and purification again.
2. experimental result
The liquid phase RT, because of different separation conditions and different chromatographic columns, RT has certain difference, but the peak sequence of each compound on liquid phase remains unchanged.Simultaneously confirm compound according to liquid chromatography mass combined instrument and marker method.
Shown in the detected result (like Figure of description 1, the HPLC of Fig. 1 compound 1 schemes spectrogram), detection compound 1 RT is 11.41min to compound 1 on analytical column, and purity is higher.Electrospray ionization mass spectrum [M+Na] peak is 941, and MW is 918 (like Figure of description 2, the EFI thing figure spectrogram of Fig. 2 compound 1).According to chromatographic retention and molecular weight, the judgement component is that (α-AMA), molecular formula is C to α-amanita hemolysin 39H 54N 10O 14S.
Compound 2 is being analyzed shown in the detected result (like Figure of description 3, the HPLC of Fig. 3 compound 2 schemes spectrogram), and detection compound 2 RTs are 7.92min.Electrospray ionization mass spectrum [M-H] peak is 918, and MW is 919 (like Figure of description 4, the EFI thing figure spectrogram of Fig. 4 compound 2).According to chromatographic retention and molecular weight, the judgement component is β-amanita hemolysin (β-AMA), molecular formula C 39H 53N 9O 15S.
In addition, also separation and purification the peptide toxoid of three kinds of the unknowns.

Claims (2)

1. the peptide toxoid is because the unique biological characteristic is widely used in biology, medical science, genetics, biological chemistry, genetically engineered, research fields such as virus at present.This research obtains to provide new resource for toxin.
2. contain α-amanita hemolysin (α-AMA) and β-amanita hemolysin (β-AMA) and other unknown toxin by the fermentation mycelium of the rose-red goose cream of preparing of claim 1.
CN2012102517812A 2012-07-20 2012-07-20 Discovery of peptide toxins in Amanita pallidorosea fermentation mycelium Pending CN102786586A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012102517812A CN102786586A (en) 2012-07-20 2012-07-20 Discovery of peptide toxins in Amanita pallidorosea fermentation mycelium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012102517812A CN102786586A (en) 2012-07-20 2012-07-20 Discovery of peptide toxins in Amanita pallidorosea fermentation mycelium

Publications (1)

Publication Number Publication Date
CN102786586A true CN102786586A (en) 2012-11-21

Family

ID=47152190

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012102517812A Pending CN102786586A (en) 2012-07-20 2012-07-20 Discovery of peptide toxins in Amanita pallidorosea fermentation mycelium

Country Status (1)

Country Link
CN (1) CN102786586A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103627757A (en) * 2013-12-02 2014-03-12 云南大学 Method for improving toxin-producing capacity of small amanita pantherina mycelia
US10111966B2 (en) 2016-06-17 2018-10-30 Magenta Therapeutics, Inc. Methods for the depletion of CD117+ cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101311260A (en) * 2007-05-24 2008-11-26 东北林业大学 Method for preparing amanita vittadinii mycelium fermentation liquor preparation
CN101376894A (en) * 2007-08-28 2009-03-04 东北林业大学 Separation and purification method for Amanita virosa antibacterial active ingredient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101311260A (en) * 2007-05-24 2008-11-26 东北林业大学 Method for preparing amanita vittadinii mycelium fermentation liquor preparation
CN101376894A (en) * 2007-08-28 2009-03-04 东北林业大学 Separation and purification method for Amanita virosa antibacterial active ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王玉玲等: "玫瑰红鹅膏主要肽类毒素的HPLC 测定及其对白色念珠菌的抑制活性", 《微生物学报》, vol. 51, no. 9, 4 September 2011 (2011-09-04), pages 1205 - 1211 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103627757A (en) * 2013-12-02 2014-03-12 云南大学 Method for improving toxin-producing capacity of small amanita pantherina mycelia
US10111966B2 (en) 2016-06-17 2018-10-30 Magenta Therapeutics, Inc. Methods for the depletion of CD117+ cells

Similar Documents

Publication Publication Date Title
CN106831596B (en) A method of preparing erythrothioneine
CN101508715B (en) Extraction and purification process for cordycepin in cordyceps militaris link
CN111018954A (en) Cyclo-serine-valine-leucine peptide with antifungal and free radical scavenging activities and preparation method thereof
CN113583094A (en) Cyclo-valine-silk-isoleucin-leucin with antifungal and free radical scavenging activities and preparation method thereof
Yang et al. Cladosporium cladosporioides XJ-AC03, an aconitine-producing endophytic fungus isolated from Aconitum leucostomum
CN103304640A (en) Method for extracting echinocandins compound from fermentation liquid
CN102786586A (en) Discovery of peptide toxins in Amanita pallidorosea fermentation mycelium
CN102630943A (en) Spirulina gamma-linolenic acid extractive and preparation method thereof
CN104447781A (en) Citrinin compound penicitrinol N derived from penicillium citrinum as well as preparation method and application thereof
CN105713069B (en) A kind of purification process of bacilysin
CN102443031A (en) Separation and purification method of c-di-GMP (cyclic diguanylate)
CN102830183B (en) Sample pre-treatment method for determining endogenesis hormone content of towel gourd seeds by adopting HPLC (High Performance Liquid Chromatography)
CN102391967B (en) Streptomycete strain and application thereof in production of actinomycin
CN103387606A (en) Method for preparing echinocandin B parent nucleus
CN103808838B (en) Extraction purification and detection analysis method for trichothecenes in potato tuber suffering dry rot
CN101649338B (en) Preparation method of single component of extracellular polysaccharide of lachnum hyalopus
CN105418602A (en) Marine peptide compound, preparation method and applications thereof
CN103898182B (en) The preparation method of beauvericin
Wei et al. Quantification of aromatic amino acids in Cordyceps fungi by micellar Electrokinetic capillary chromatography
CN105646627B (en) A method of the extraction purification cordycepin from Cordyceps militaris culture solution
CN102559620B (en) Benzo[a]pyrene degrading enzyme and separation method thereof
CN103667073B (en) Huperzia serrata endogenetic epiphyte and the application in preparation pyroles liver-protecting medicine thereof
CN103194502B (en) Separating and purifying method of taxol synthesized by biological fermentation of nodulisporium sylviforme entophytic fungi as well as precursors of taxol
CN103484505B (en) Method for generating resveratrol by converting glucose by using intracellular enzyme of alternaria microorganism
CN102001921B (en) Sesquiterpene hybrid hydroquinone compounds and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121121